Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Picconi

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
Current Pharmaceutical Design|September 11, 2008
The endocannabinoid system in Parkinson's diseaseMassimiliano Di Filippo, Barbara Picconi, Alessandro Tozzi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2016
Early synaptic dysfunction in Parkinson's disease: Insights from animal modelsTommaso Schirinzi, Graziella Madeo, Giuseppina Martella, et al.
Neurotoxicology|June 2, 2005
Pathological synaptic plasticity in the striatum: implications for Parkinson's diseaseBarbara Picconi, Antonio Pisani, Ilaria Barone, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 16, 2002
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptorsDiego Centonze, Barbara Picconi, Christelle Baunez, et al.
Neuropharmacology|March 25, 2008
Plasticity and repair in the post-ischemic brainMassimiliano Di Filippo, Alessandro Tozzi, Cinzia Costa, et al.
European Journal of Pharmacology|July 21, 2006
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibitionMassimiliano Di Filippo, Barbara Picconi, Cinzia Costa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 24, 2004
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptorsDiego Centonze, Alessandro Usiello, Cinzia Costa, et al.
Neuropharmacology|February 28, 2006
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholineBarbara Picconi, Ilaria Barone, Antonio Pisani, et al.
Brain : a Journal of Neurology|November 14, 2002
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatmentBarbara Picconi, Antonio Pisani, Diego Centonze, et al.
Neurobiology of Disease|September 25, 2002
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatumMaddalena Napolitano, Diego Centonze, Angelica Calce, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Current Pharmaceutical Design|September 11, 2008
The endocannabinoid system in Parkinson's diseaseMassimiliano Di Filippo, Barbara Picconi, Alessandro Tozzi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2016
Early synaptic dysfunction in Parkinson's disease: Insights from animal modelsTommaso Schirinzi, Graziella Madeo, Giuseppina Martella, et al.
Neurotoxicology|June 2, 2005
Pathological synaptic plasticity in the striatum: implications for Parkinson's diseaseBarbara Picconi, Antonio Pisani, Ilaria Barone, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 16, 2002
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptorsDiego Centonze, Barbara Picconi, Christelle Baunez, et al.
Neuropharmacology|March 25, 2008
Plasticity and repair in the post-ischemic brainMassimiliano Di Filippo, Alessandro Tozzi, Cinzia Costa, et al.
European Journal of Pharmacology|July 21, 2006
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibitionMassimiliano Di Filippo, Barbara Picconi, Cinzia Costa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 24, 2004
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptorsDiego Centonze, Alessandro Usiello, Cinzia Costa, et al.
Neuropharmacology|February 28, 2006
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholineBarbara Picconi, Ilaria Barone, Antonio Pisani, et al.
Brain : a Journal of Neurology|November 14, 2002
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatmentBarbara Picconi, Antonio Pisani, Diego Centonze, et al.
Neurobiology of Disease|September 25, 2002
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatumMaddalena Napolitano, Diego Centonze, Angelica Calce, et al.
Pageof 14